G01N 2333/91245
Nucleotidyltransferases
Official title: Nucleotidyltransferases (2.7.7)
G01N2333/91245 (Nucleotidyltransferases) appears on 167 US grants and 301 published applications in this corpus.
Search patents in G01N- Granted patents
- 167
- Published applications
- 301
- Assignees
- 185
- Inventors
- 680
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 7 | 0 |
| 1999 | 5 | 0 |
| 2000 | 4 | 0 |
| 2001 | 4 | 1 |
| 2002 | 1 | 4 |
| 2003 | 3 | 13 |
| 2004 | 1 | 7 |
| 2005 | 3 | 9 |
| 2006 | 3 | 11 |
| 2007 | 6 | 15 |
| 2008 | 3 | 8 |
| 2009 | 3 | 7 |
| 2010 | 2 | 12 |
| 2011 | 3 | 12 |
| 2012 | 10 | 14 |
| 2013 | 9 | 5 |
| 2014 | 7 | 8 |
| 2015 | 6 | 15 |
| 2016 | 7 | 9 |
| 2017 | 8 | 17 |
| 2018 | 3 | 11 |
| 2019 | 17 | 11 |
| 2020 | 7 | 15 |
| 2021 | 7 | 17 |
| 2022 | 6 | 11 |
| 2023 | 11 | 8 |
| 2024 | 5 | 30 |
| 2025 | 5 | 22 |
| 2026 | 7 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Cyanine dyes12 May 2026US 12,624,391 B2Pacific Biosciences of California, Inc.
- Enhancing anti-tumor response in melanoma cells with defective sting signaling14 Apr 2026US 12,599,621 B2H. Lee Moffitt Cancer Center
- Methods and uses of enzymatic labeling of ADP-ribose containing molecules14 Apr 2026US 12,601,734 B2Cold Spring Harbor Laboratory
- Screening method for telomerase reverse transcriptase (TERT) phosphorylation inhibitors17 Mar 2026US 12,577,555 B2
- Systems and methods for selective DNA multiple displacement amplification of a DNA mixture17 Mar 2026US 12,577,613 B2Genomic Labs Ltd
- Integrated device for single-step extraction and affinity capture of analytes from dried biological samples27 Aug 2026US 2026/0251649 A1QuantiScientifics, LLC
- Semi-quantitative electrochemical biosensor system and method for pathogenic organism nucleic acid detection13 Aug 2026US 2026/0233218 A1eDNA Biotech, Inc.
- Distinctive identification and use of a liquid biopsy cancer biomarker for cancer detection, management and treatment6 Aug 2026US 2026/0227409 A1Rarecells SAS
- Development of a rapid enzymatic assay for antiretroviral drug monitoring using crispr reporters21 May 2026US 2026/0139294 A1University of Washington
- Cyanine derivatives and related uses7 May 2026US 2026/0125751 A1Element Biosciences, Inc.
Most cited
By later US patents
- Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase152US 5,503,978 AUniversity Research Corporation · 1996
- Therapy and diagnosis of conditions related to telomere length and/or telomerase activity143US 5,489,508 AUniversity of Texas System Board of Regents · 1996
- High affinity ssDNA ligands of HIV-1 reverse transcriptase113US 5,786,462 ANeXstar Pharmaceuticals, Inc. · 1998
- Methods for identifying a location of an RNA in a biological sample78US 11,761,038 B110x Genomics, Inc. · 2023
- Promoter for telomerase reverse transcriptase59US 6,610,839 B1Geron Corporation · 2003